Early days of Ion Bm Rx in...
Transcript of Early days of Ion Bm Rx in...
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Early Days of Ion Beam Therapy in US
Jose R. Alonso,!LBNL (Retired)!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
THANKS!!
And many wonderful memories… • Meinhard Regler!• Phil Bryant!• Michael Benedikt!• Horst Schonauer!• Thomas Auberger!• Marius Pavlovic!• ….!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Early work at Berkeley !E.O. Lawrence placed strong emphasis on medical uses of his cyclotrons (1930ʼs)!
!Robert Wilson proposed
use of Bragg Peak for radiation therapy (1946)
John Lawrence, Cornelius Tobias, Thomas Budinger
and others pioneered biomedical
applications of high-energy beams
(>1950)!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
184” SynchroCyclotron
ISAH"(Isocentric Stereotactic "
Apparatus for Humans)"Submillimeter accuracy"
Commissioned ~ 1948"Pituitary ablation – protons"Large field therapy- helium"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Development of the Bevalac
• In 1974, Transfer Line was completed, connecting the SuperHILAC (built in 1958) to the Bevatron (built in 1954)"
• Thus was formed the world’s first accelerator capable of producing high-energy (>1 GeV/amu) beams of any element of the periodic table"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Heavy Ions!!
Single Holmium ion (Z=67, A=165) at 1 GeV/amu ""in Streamer Chamber (1 atm He/Ne)"
1 meter"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
More like it!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Life-Sciences Programs at Bevalac
• 1/3 of all Bevalac time was dedicated to Life Sciences!• Dedicated Biomedical area consisted of:!
– Two therapy rooms"– One biology/biophysics area"– Support facilities and staging areas"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
From a “Cave” into a “Treatment Room”
(We still referred to it as “Cave I”)!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Therapy Program
• Neon ions used for majority of patients!
• Horizontal beam delivery!
• Large fields (up to 28 cm diameter)!
• Mechanical field shaping/collimation!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Developed New Beam Delivery Concepts
• Goals:!– Better conformation of dose to
irregular shape""– Better utilization of ions"
• Decrease in fragmentation losses""
– Maintaining sharp field edges"• Reduction in scattering, straggling"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Double-Scattering
• First Scatterer – < 1 cm Pb (ΔE ~ 100 MeV/amu)!• Concentric brass rings & 2nd scatterer!• Brass ridge filters (Spiral)!• Water column!• Patient collimator !
"(cerrobend)"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Wobbler
• Sweep field in circular pattern!– Several concentric circles make
up full field"• Lateral, transverse shaping with
collimators, bolus compensators!• Significant improvements in beam
quality!
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Raster Scanner
• Small beam spot swept in raster pattern across rectangular field!
• Bevalac system still employed collimators for field shaping!– Full 3-D system (currently used at GSI) not possible at
Bevalac due to old accelerator technology""
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Radioactive Beams! Ne19
Ne20
~1cm Be
Peripheral collision
More central collision (Mess)
Ne20
Be
Be
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Radioactive Beams!
PET Image of line beam stopped in phantom!– ! Stopping point modulated with bolus to simulate "
" "chordoma treatment"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Clinical Experience - 1977-1993
• 1200 patients treated at LBNL!– 184-Inch Synchrocyclotron and Bevalac"
• 433 patients received treatments at Bevalac !– Mostly neon ions used, either as full treatment or
boost for helium treatments"• Emphasis on dose-localization, e.g.!
– Scull-base, sinus cavities"– Ocular melanoma"
• And sites benefiting from high LET, e.g.!– Salivary gland"– T3-T4 prostate"
• Clinical results “interesting”!– Follow-ons continue today!"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Lessons Learned from Bevalac
• Clinical use of light-ion beams is clearly feasible, and definitely worth pursuing!– Even with simple delivery techniques, results were
substantially better than current practice"• Most effective use of light-ion beams requires
very sophisticated beam-delivery technology!– Achieving 3-D conformation to irregular target
shapes is very difficult to do"• Sharing major accelerator facility between
different research communities is very difficult!– Incompatibilities of resource/schedule needs for
optimum conduct of programs"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Current Picture in the US
• Bevalac shut down in 1993!– Fiscal constraints on Nuclear Physics program"– Note: Therapy Grant had been renewed with
excellent (and guaranteed-fundable) score!"• Today, Proton therapy is thriving!
– 8 operational facilities"– Many more in the pipeline"
• No Light-Ion facilities planned!– Primary hurdle: financial"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Why??
• Large facilities for health-care research do not receive government subsidies or funding!– All proton facilities privately funded"
• Must make money to repay investors"
– High capital cost of Light-Ion facility is a great problem"
• Government agencies funding science not optimally structured to address needs for hadron therapy facility construction!– DOE builds large capital research facilities, but
NOT for health care"– NIH funds research but does not build facilities"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
The Future…
• Leadership in Ion Beam Therapy now in Japan and Europe!– Wonderful example here in Wiener Neustadt of
technical/government/community partnership to bring MedAUSTRON to reality"
• US will have a difficult time catching up, even in presence of overwhelmingly positive clinical evidence!– It will not happen without major changes in policy
for funding large research clinical facilities"
B ERKELEY L ABAccelerator and Fusion Research Division Ion Beam Technology Program
Congratulations!